111 related articles for article (PubMed ID: 13285966)
21. Chemotherapeutic activity of 6-sulfanilamido-2,4-dimethylpyrimidine (elkosin).
EISMAN PC; GEFTIC SG; LIGENZOWSKI F; MAYER RL
Proc Soc Exp Biol Med; 1952 Jul; 80(3):493-5. PubMed ID: 14949095
[No Abstract] [Full Text] [Related]
22. [Remote results of penicillin and sulfanilamide therapy of gonorrhea in women].
TURANOVA EN; DAKHSHLEIGER EK; PAK TI; IASKOLKO FM
Akush Ginekol (Mosk); 1955; 1():61-4. PubMed ID: 14376306
[No Abstract] [Full Text] [Related]
23. On the action of sulfanilamide; the mechanism of action of sulfanilamide derivatives in vitro.
JULIUS HW; WINKLER KC
Antonie Van Leeuwenhoek; 1944-1945; 10(1-2):1-11. PubMed ID: 20990851
[No Abstract] [Full Text] [Related]
24. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
[TBL] [Abstract][Full Text] [Related]
25. [The distribution of sulfonamides in the female genital organs and their passage through the placental barrier to the human fetus].
HELD E; EGGER P
Gynaecologia; 1946 Mar; 121():133-41. PubMed ID: 20988444
[No Abstract] [Full Text] [Related]
26. Trends in the prevalence of venereal diseases in England and Wales.
WILLCOX RR
Br J Vener Dis; 1962 Dec; 38(4):189-99. PubMed ID: 14000786
[No Abstract] [Full Text] [Related]
27. TREATMENT OF MARINERS SUFFERING FROM URETHRITIS BEFORE ATTENDANCE AT A VD CLINIC.
SCHOFIELD CB
Br J Vener Dis; 1964 Sep; 40(3):181-90. PubMed ID: 14210484
[No Abstract] [Full Text] [Related]
28. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance.
Wang SA; Harvey AB; Conner SM; Zaidi AA; Knapp JS; Whittington WL; del Rio C; Judson FN; Holmes KK
Ann Intern Med; 2007 Jul; 147(2):81-8. PubMed ID: 17638718
[TBL] [Abstract][Full Text] [Related]
29. Fundamental problems for laboratory research on Neisseria gonorrhoeae and gonococcal infection.
HILL JH
Am J Syph Gonorrhea Vener Dis; 1948 Mar; 32(2):165-89. PubMed ID: 18902200
[No Abstract] [Full Text] [Related]
30. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
[TBL] [Abstract][Full Text] [Related]
31. Neisseria gonorrhoeae vaccine development: hope on the horizon?
Edwards JL; Jennings MP; Seib KL
Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
[TBL] [Abstract][Full Text] [Related]
32. Structure and activity of sulfanilamides.
BORDWELL FG; COLBERT AB; ALAN B
J Am Chem Soc; 1946 Sep; 68(9):1778-81. PubMed ID: 21001092
[No Abstract] [Full Text] [Related]
33. Chemotherapeutic activity of some sulfapyridine-1-oxides.
SCUDI JV; PLEKSS OJ
Proc Soc Exp Biol Med; 1958 Mar; 97(3):639-41. PubMed ID: 13518359
[No Abstract] [Full Text] [Related]
34. Antibacterial action of an oxidation product of sulfanilamide.
BARKAN G; GOLDSMITH L
J Am Chem Soc; 1946 May; 68():733. PubMed ID: 21024868
[No Abstract] [Full Text] [Related]
35. Treatment of male gonorrhoea with a chlortetracycline-sulphonamide combination.
THOMSON GM
Br J Vener Dis; 1959 Dec; 35(4):254-5. PubMed ID: 13838153
[No Abstract] [Full Text] [Related]
36. [Clinical and bacteriological studies on neonatal conjunctiva with special consideration of gonorrhea prevention].
THOMAS J; LEGLER F; LEUXNER E
Arch Gynakol; 1953 Oct; 182(6):707-27. PubMed ID: 13125420
[No Abstract] [Full Text] [Related]
37. Increasing resistance of Neisseria gonorrhoeae in west and central Africa. Consequence on therapy of gonococcal infection.
Van Dyck E; Crabbé F; Nzila N; Bogaerts J; Munyabikali JP; Ghys P; Diallo M; Laga M
Sex Transm Dis; 1997 Jan; 24(1):32-7. PubMed ID: 9018781
[TBL] [Abstract][Full Text] [Related]
38. Incidence of disseminated gonococcal infection correlated with the presence of AHU auxotype of Neisseria gonorrhoeae in a community.
Noble RC; Reyes RR; Parekh MC; Haley JV
Sex Transm Dis; 1984; 11(2):68-71. PubMed ID: 6431620
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
[TBL] [Abstract][Full Text] [Related]
40. The lipopolysaccharide (R type) as a common antigen of Neisseria gonorrhoeae. I. Immunizing properties.
Diena BB; Ashton FE; Ryan A; Wallace R
Can J Microbiol; 1978 Feb; 24(2):117-23. PubMed ID: 417780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
